Full-Time
Posted on 9/12/2025
Cyber insurance paired with risk-quantifying SaaS
$21.50 - $32/hr
Sharonville, OH, USA
In Person
| , , , |
Resilience provides cyber insurance to mid-market and large enterprises and licenses the Resilience Solution, a SaaS platform that translates a company’s security posture into a financially oriented action plan used for underwriting and risk management. The platform quantifies technology controls, estimates ROI of security investments, and informs insurance pricing. It runs a risk operations center with continuous threat intelligence and in-house claims handling, emphasizing third-party risk. Goal: move beyond risk transfer by actively improving client security and reducing losses across sectors such as manufacturing, agriculture, and healthcare.
Company Size
1,001-5,000
Company Stage
Grant
Total Funding
$2.5B
Headquarters
San Diego, California
Founded
2020
Help us improve and share your feedback! Did you find this helpful?
People at Resilience who can refer or advise you
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Company Match
Unlimited Paid Time Off
Paid Holidays
Family Planning Benefits
Fertility Treatment Support
Tuition Reimbursement
Performance Bonus
InvestorNewsBreaks - Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) Collaborates with Resilience Biosciences on AI-Driven Drug Discovery. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) announced a collaboration with Resilience Biosciences Inc. to support the development and evaluation of AI-assisted computational chemistry workflows for small-molecule drug development, with the goal of improving efficiency in identifying, analyzing and advancing potential drug candidates. The collaboration will apply Redwood's computational chemistry, cheminformatics and synthetic route design capabilities to support Resilience's non-opioid therapeutic development programs, including workflows for derivative generation, patentability and freedom-to-operate analysis, and retrosynthetic planning aimed at accelerating early-stage drug discovery and development. About Redwood AI Corp. Redwood AI uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood AI's platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications. About InvestorWire InvestorWire ("IW") is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge. Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer InvestorWire is powered by IBN
PRESS RELEASE: Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
Mahatme brings over 30 years of executive leadership experience in the biopharmaceutical industry, most recently serving as President, COO, and CFO of National Resilience, where he raised over $2.5 billion in capital.
CISC researchers to present at the 66th edition of the ESReDA Seminar on transformative Safety and Resilience in a digital, Sustainable World.
Resilience, self-love, co-regulation and the importance of remembering fun are some of the key educational themes for this year's Yampa Valley Wellness Conference organized by the nonprofit Health Partnership serving Northwest Colorado.